TriLink BioTechnologies & Aldveron ink non-exclusive license and supply agreement for CleanCap mRNA capping technology: San Diego, US Thursday, February 6, 2025, 15:00 Hrs [IST] T ...

Oxford, UK – 5 February 2025: OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today announces the appointment of Jefferies International Limited ("Jefferies") as its Joint ...

In the field of biopharmaceuticals, every technological innovation has the potential to revolutionize treatment strategies. Sanyou Bio's Intelligent Hundred-Trillion Molecule Library (AI-STAL) has ...

TriLink BioTechnologies, a Maravai LifeSciences (MRVI) company and global provider of life science reagents and services, has signed a ...

TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science ...

PRNewswire Bangalore Karnataka [India] 3 New York-based VJ Group announced the launch of its newest venture VJ Bio a biotech ...

WEST JEFFERSON, OHIO / ACCESS Newswire / January 30, 2025 / AmplifyBio, a leading preclinical CRO and CDMO played a pivotal ...

The Howard Hughes Medical Institute has named Fred Hutch Cancer Center postdoctoral researcher Grant King, PhD, a Hanna H.

IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Gearing Up to Initiate Phase 3 Ovarian Cancer Trial Imunon, Inc. (NASDAQ:IMNN) is continuing preparations to conduct a Phase 3 clinical trial of ...

John Innes Centre researchers and partners used a model plasmid called RK2 that is used globally to study clinically relevant plasmids that transmit antimicrobial resistance. Their initial focus was a ...

John Innes Centre researchers and partners used a model plasmid called RK2 that is used globally to study clinically relevant plasmids that transmit antimicrobial resistance. Their initial focus was a ...